The investment seeks to provide long-term growth of capital primarily through investment in equity securities; current income is a secondary objective... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category LargeValue
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XMLV | 62.64 | 0.30 | +0.48% |
Invesco S&P MidCap Low Volatility ETF | |||
JEPQ | 54.16 | 0.18 | +0.33% |
JPMorgan Nasdaq Equity Premium Inc ETF | |||
JULW | 37.28 | 0.06 | +0.16% |
AllianzIM US Large Cap Buffer20 Jul ETF | |||
VABS | 24.45 | -0.01 | -0.04% |
Virtus Newfleet ABS/MBS ETF | |||
BIS | 16.74 | -0.15 | -0.89% |
ProShares UltraShort Nasdaq Biotech |
A.I.dvisor indicates that over the last year, JDVNX has been closely correlated with RMFEX. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if JDVNX jumps, then RMFEX could also see price increases.
Ticker / NAME | Correlation To JDVNX | 1D Price Change % | ||
---|---|---|---|---|
JDVNX | 100% | N/A | ||
RMFEX - JDVNX | 80% Closely correlated | +0.64% | ||
RMFCX - JDVNX | 80% Closely correlated | +0.66% | ||
RMEBX - JDVNX | 80% Closely correlated | +0.64% | ||
FFFMX - JDVNX | 80% Closely correlated | +0.64% | ||
VIVAX - JDVNX | 79% Closely correlated | N/A | ||
More |